Global /Australia /Healthcare /Medical Devices /VHL

Vitasora Health Ltd.

VHL

• ASX: VHL • Delayed

0.0160AUD -20%

0.0113 USD

As of 10 June 2026, Vitasora Health Ltd. has a market cap of $27.28M USD, ranking #34868 globally and #952 in Australia. It ranks #3144 in the Healthcare sector, and #670 in the Medical Devices industry.

Global Rank

34868

Country Rank

952

Sector Rank

3144

Industry Rank

670

Key Stats

Market Cap

$27.28MUSD

38.79M AUD

Enterprise Value

$25.17MUSD

35.72M AUD

Revenue (TTM)

$3.52MUSD

5.01M AUD

EBITDA (TTM)

-$8.13MUSD

-11.53M AUD

Net Income (TTM)

-$8.15MUSD

-11.59M AUD

EBITDA Margin

-230%

Profit Margin

-231%

Forward PE

13.3

PS Ratio

7.7

PB Ratio

2.3

Company Profile

Country (HQ)

Australia

Sector

Healthcare

Industry

Medical Devices

CEO

Marjan Mikel open_in_new

Employees

Founded

1987

Website

vitasorahealth.com.au open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-20%	-4.8%	-17%	-4.8%	-38%	-17%	-46%	-60%	-84%

News

Markets

Exchange	Ticker	Price	Quotes
Australian Securities Exchange (ASX) MIC: XASX PRIMARY	VHL Vitasora Health Ltd ISIN: AU0000392748 Shares Out.: Shares Outstanding: 1.94B¹ Shares Float: 1.766B² TV: TradingView: ASX: VHL SA: Stock Analysis: ASX: VHL YF: Yahoo Finance: VHL.AX GF: Google Finance: ASX: VHL BA: Barron's: VHL MS: Morningstar: XASX: VHL	0.0160 AUD	TV: TradingView: ASX: VHL SA: Stock Analysis: ASX: VHL YF: Yahoo Finance: VHL.AX GF: Google Finance: ASX: VHL BA: Barron's: VHL MS: Morningstar: XASX: VHL
OTC Markets (OTCMKTS / OTC) MIC: OTCM	VHLUF Vitasora Health Ltd ISIN: AU0000392748 Shares Out.: Shares Outstanding: 1.577B¹ Shares Float: 1.409B² TV: TradingView: OTC: VHLUF SA: Stock Analysis: OTC: VHLUF YF: Yahoo Finance: VHLUF GF: Google Finance: OTCMKTS: VHLUF BA: Barron's: VHLUF MS: Morningstar: PINX: VHLUF	0.0581 USD	TV: TradingView: OTC: VHLUF SA: Stock Analysis: OTC: VHLUF YF: Yahoo Finance: VHLUF GF: Google Finance: OTCMKTS: VHLUF BA: Barron's: VHLUF MS: Morningstar: PINX: VHLUF

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Vitasora Health Ltd.

Vitasora Health Limited researches, develops, and commercializes medical devices in Australia and the United States. It is also involved in the production of mobile health applications. The company was formerly known as Respiri Limited and changed its name to Vitasora Health Limited in April 2025. The company is headquartered in Melbourne, Australia.

Similar Companies

Industry: Medical Devices (Australia)

Name	Market Cap (USD) diff.	PE	Country
Cochlear Ltd. ASX: COH	$4.14B 5.89B AUD 15K%	17.1	Australia
EBOS Group Ltd. NZE: EBO	$2.53B 4.34B NZD 9K%	16.0	Australia
Clarity Pharmaceuticals Ltd. ASX: CU6	$774.93M 1.1B AUD 3K%	-	Australia
Nanosonics Ltd. ASX: NAN	$732.34M 1.04B AUD 3K%	52.3	Australia
Tetratherix Ltd. ASX: TTX	$168.51M 239.61M AUD 518%	-	Australia
Orthocell Ltd. ASX: OCC	$167.91M 238.75M AUD 515%	-	Australia

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 635K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 589K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 583K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 464K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 442K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 373K%	22.2	Ireland

chevron_leftBack